Lux Biosciences to Present at Lazard Capital Markets 6th Annual Healthcare Conference

16 Nov 2009

·www.biospace.com

JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Brett Skolnik, Chief Financial Officer, will present a company overview at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th, 2009 at 10:00 a.m. ET. The conference is ongoing November 17–19 at the St. Regis Hotel, New York City.

Organizations

Lux Biosciences, Inc.

Indications

Eye Diseases

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.